BiotechTube
Home/Mendus/Sven Andreasson
SA

Sven Andreasson

Chairman of the Board

Mendus

Therapeutic Areas

OncologyHematology

Mendus Pipeline

DrugIndicationPhase
Vididencel (DCP-001)Acute Myeloid Leukemia (AML) - Maintenance for MRD+Phase 2
IlixadencelSolid Tumors (RCC, HCC, GIST) - Intratumoral primerPhase 1/2

Leadership Team at Mendus

EM
Erik Manting
Chief Executive Officer
TM
Tariq Mughal
Chief Medical and Scientific Officer
LF
Lotta Ferm
Chief Financial Officer
View full Mendus profile